The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The effect of treatment with selective serotonin reuptake inhibitors in comparison to placebo in the progression of dementia: a systematic review and meta-analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Studies investigating the relationship between antidepressant use and AD/ADRD risk have yielded conflicting results.
“Studies looking into this question, however, have yielded conflicting results. 4-7”
From Antidepressant exposure and long‐term dementia risk in a nationwide retrospective study on US veterans with midlife major depressive disorder (2024) · cites this paper as [7]
The Background (page unavailable) describes mixed findings on whether SSRIs affect cognition in people who already have dementia. The Abstract likewise concerns SSRI treatment after a dementia diagnosis. Neither passage addresses whether antidepressant use is associated with the risk of developing AD or related dementias; searches for that risk and for conflicting results found no such discussion. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Citalopram on Agitation in Alzheimer Disease: The CitAD Randomized Clinical Trial
Porsteinsson, A. P., Drye, L. T., Pollock, B. G., Devanand, D. P., Frangakis, C., Ismail, Z., Marano, C., Meinert, C. L., Mintzer, J. E., Munro, C. A., et al. (2014) · JAMA · doi:10.1001/jama.2014.93 · Cited by 572
Lyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398
Flagged first, then by citations
Research works printed but not linked: 25
- Richards, 2011, Antidepressants for pain management in rheumatoid arthritis, Cochrane Database Syst Rev, 11, CD008920
- 10.4088/JCP.v60n0107 · DOI
- Seitz DP , Adunuri N , Gill SS , Gruneir A , Herrmann N , Rochon P . Antidepressants for agitation and psychosis in dementia. Cochrane Database Syst Rev 2011; CD008191. · DOI · Paper page
- Richards BL , Whittle SL , Buchbinder R . Antidepressants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev 2011; CD008920. · DOI
- 10.1097/00001756-200207020-00021 · DOI
- 10.1097/FBP.0b013e3282ee2aa8 · DOI
- Siepmann, 2015, Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence, Brain Behav, 5, e00373, 10.1002/brb3.373 · DOI
- 10.1002/jnr.21899 · DOI
- Chow, 2007, Potential cognitive enhancing and disease modification effects of SSRIs for Alzheimer's disease, Neuropsychiatr Dis Treat, 3, 627
- Dixon, 2013, Selective serotonin reuptake inhibitors for mild cognitive impairment: a systematic review, J Neurol Disord Stroke, 1, 1022
- 10.1007/s40266-012-0012-5 · DOI · Paper page
- 10.1177/1756285612455733 · DOI
- Auer SR , Monteiro I , Torossian C , Sinaiko E , Boksay I , Reisberg B . The treatment of behavioral symptoms in dementia: haloperidol, thioridazine, and fluoxetine: a double blind, placebo controlled eigth month study. In: Fifth International Conference on Alzheimer's Disease and Related Disorders, Osaka, Japan, July 24–29, 1996. · DOI
- Banerjee, 2013, Study of the use of antidepressants for depression in dementia: the HTA-SADD trial—a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine, Health Technol Assessment, 17, 1, 10.3310/hta17070 · DOI
- Alderson P , Green S , Higgins JPT , eds. Assessment of Study Quality. Cochrane Reviewers’ Handbook , 4.2.2 updated March 2004]; Section 6. The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, Ltd, 2004.
- Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
- 10.1007/s00213-003-1686-5 · DOI
- Weintraub, 2010, Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes, Am J Geriatr Psychiatry, 8, 332, 10.1097/JGP.0b013e3181cc0333 · DOI
- 10.1002/gps.998 · DOI
- Petracca, 2001, A double-blind, placebo-controlled study of fluoxetine in depressed participants with Alzheimer's disease, Int Psychogeriatr, 13, 233, 10.1017/S104161020100761X · DOI
- 10.1176/appi.ajp.159.3.460 · DOI · Paper page
- 10.1111/j.1600-0447.1992.tb03211.x · DOI
- 10.1097/jcp.0b013e31814b98c1 · DOI · Paper page
- Nyth, 1991, A controlled multicenter clinical study of citalopram and placebo in elderly depressed participants with and without dementia, Acta Psychiatry Scand, 86, 138, 10.1111/j.1600-0447.1992.tb03242.x · DOI · Paper page
- 10.1212/WNL.51.6.1546 · DOI · Paper page
Cited by
Sorted by citations
Xie, Y., Liu, P.-P., Lian, Y.-J., Liu, H.-B., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0064-7 · Cited by 49
Sheline, Y. I., Snider, B. J., Beer, J. C., Seok, D., Fagan, A. M., Suckow, R. F., Lee, J.-M., Waligorska, T., Korecka, M., Aselcioglu, I., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010725 · Cited by 45
Ramos‐Cejudo, J., Corrigan, J. K., Zheng, C., Swinnerton, K. N., Jacobson, S. R., La, J., Betensky, R. A., Osorio, R. S., Madanes, S., Pomara, N., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13853 · Cited by 11
Metadata
- Authors
- Jones, H. E., Joshi, A., Shenkin, S., & Mead, G. E.
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-04-07
- Volume
- 45
- Issue
- 4
- Pages
- 448-456
- ISSN
- 0002-0729
- 1468-2834
- Cited by
- 35
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
